Figure 1.

Case ascertainment of IIDD in IBD patients with and without anti-TNFα exposure.
Inflammatory bowel disease (IBD), Crohn’s disease (CD), Ulcerative colitis (UC), anti-tumor necrosis factor alpha (anti-TNFα), idiopathic inflammatory-demyelinating disease of the central nervous system (IIDD)